Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes

Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Basal/Bolus Therapy for Patients With Gestational Diabetes

This trial is conducted in the United States of America (USA). The purpose of this study is to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to regular human insulin for the control of blood glucose after meals in women who develop diabetes during pregnancy.

Inclusion Criteria:

• Subjects older than 35 years old will be considered
• Gestational diabetes mellitus